Survival after ICI therapy was worse in patients with EMT-high/PD-L1-high NSCLC than in patients EMT-low/PD-L1-high NSCLC, but there were no differences in survival according to EMT in patients with PD-L1-low NSCLC. The gene discussed is CD274; the disease is non-small cell lung carcinoma.